CeQur lands CE Mark for its PaQ continuous insulin delivery device

November 29, 2012 by MassDevice staff

CeQur SA receives CE Marked approval to commercialize PaQ insulin delivery devices in the European market.

CeQur logo

CeQur SA received CE Mark approval to commercialize its PaQ insulin delivery devices in the European market, the company reported this week.

The PaQ insulin delivery system features a disposable insulin-infuser reservoir attached to a reusable insulin monitor and provides 3 days of continuous basal insulin delivery and on-demand bolus insulin for individuals with Type II diabetes, the company said.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp